iShares LifePath Target Date 2045 ETF USD

iShares LifePath Target Date 2045 ETF USD is offered by iShares, a leading player in the field of passive investments.

The total expense ratio of iShares LifePath Target Date 2045 ETF USD is 0.11%, which means that investors pay 11 USD per 10,000 USD in investment capital annually.

The ETF is listed in USD.

European investors may incur additional costs for currency exchange and transaction fees.

No, iShares LifePath Target Date 2045 ETF USD does not comply with the EU UCITS investor protection directives.

The current average trading volume of iShares LifePath Target Date 2045 ETF USD is 16,560.09.

iShares LifePath Target Date 2045 ETF USD is domiciled in US.

The fund was launched on 10/17/2023.

The iShares LifePath Target Date 2045 ETF USD mainly invests in Target date companies.

The NAV of iShares LifePath Target Date 2045 ETF USD amounts to 37.91 M USD.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.